Positive regulation of muscle hypertrophy

pathway activity — cross-omics
GO:0014742Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Positive regulation of muscle hypertrophy pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are SPTBN1, RPL4, and MYO9B_S1405, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Positive regulation of muscle hypertrophy activity versus SPTBN1 in GBM (Pearson r = 0.40).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMSPTBN1 →+0.260+0.037.005.00735
BRCARPL4 →-0.331-0.032.001.00634
BRCAMYO9B_S1405 →+0.545+0.054<.001<.00134
BRCANOC2L →-0.240-0.037.007.00234
LSCCTUBA4A →+0.398+0.043.002.00734
COADENSA_S109 →-0.870-0.042<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0014742 vs SPTBN1 — GBM

Per-sample scatter of Positive regulation of muscle hypertrophy activity vs SPTBN1 in GBM.

Explore this scatter interactively →

Exploration